PYCPYC THERAPEUTICS LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 18 Aug 2026, 18:16 | Investor Webinar | Presentations | — | 14014 | |
| 14 Aug 2026, 21:02 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 14 Aug 2026, 00:42 | Notification regarding unquoted securities - PYC | Other | — | 06021 | |
| 29 July 2026, 18:45 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 22 July 2026, 18:20 | PKD - Safety Committee Approves Dose Escalation | Company Update | MS | 11001 | |
| 21 July 2026, 18:32 | ADOA Program Update | Company Update | MS | 11001 | |
| 21 July 2026, 05:03 | Notification of cessation of securities - PYC | Other | — | 06027 | |
| 20 July 2026, 18:28 | Presentation At 2026 PMS Foundation Family Conference | Presentations | — | 03026 | |
| 16 July 2026, 04:12 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 8 July 2026, 19:01 | Grant of Patents by the US Patent Office | Company Update | — | 11001 | |
| 7 July 2026, 18:21 | Appointment of Chief Financial Officer | Company Administration | — | 12008 | |
| 18 June 2026, 18:26 | Notification of cessation of securities - PYC | Other | — | 06027 | |
| 17 June 2026, 02:29 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 16 June 2026, 01:01 | Company Secretary Appointment/Resignation | Company Administration | — | 12007 | |
| 13 June 2026, 01:55 | Notice of General Meeting/Proxy Form | Meetings & Governance | — | 08004, 08007, 16002 | |
| 27 May 2026, 05:23 | Change to CEO remuneration | Company Administration | — | 12008 | |
| 22 May 2026, 19:17 | 2026 Q2 Investor Webinar Presentation | Presentations | — | 03026 | |
| 19 May 2026, 05:06 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 12 May 2026, 19:07 | Investor Webinar | Presentations | — | 14014 | |
| 12 May 2026, 04:56 | Notification of cessation of securities - PYC | Other | — | 06027 | |
| 7 May 2026, 19:03 | PKD - Initiation of Multiple Dose Clinical Trial | Company Update | MS | 11001 | |
| 4 May 2026, 19:14 | Presentation of Ophthalmology Clinical Trial Data at ARVO | Presentations | MS | 03026 | |
| 29 Apr 2026, 04:44 | Exercise of Options and Cleansing Notice | Securities Administration | — | 06009, 06018 | |
| 29 Apr 2026, 04:34 | Application for quotation of securities - PYC | Other | — | 06020 | |
| 28 Apr 2026, 19:12 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 27 Apr 2026, 19:48 | Orphan Drug Designation Granted for RP11 by EMA | Company Update | — | 11001 | |
| 15 Apr 2026, 20:53 | ADOA Program - SRC Approve Progression to Multi-Dose Study | Company Update | MS | 11001 | |
| 2 Apr 2026, 07:25 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 28 Mar 2026, 00:17 | Change of Director's Interest Notice RH | Director Interests | — | 02009 | |
| 27 Mar 2026, 20:58 | PKD - Presentation at World Congress of Nephrology | Company Update | — | 03026, 11001 | |
| 24 Mar 2026, 20:01 | ADOA Program - Presentation at NANOS 2026 | Company Update | — | 03026, 11001 | |
| 16 Mar 2026, 20:19 | Regulatory Alignment on Registrational Trial Requirements | Company Update | — | 11001 | |
| 11 Mar 2026, 05:41 | Change of Director's Interest Notice RH IC | Director Interests | — | 02009 | |
| 10 Mar 2026, 06:55 | Application for quotation of securities - PYC | Other | — | 06020 | |
| 6 Mar 2026, 20:46 | Application for quotation of securities - PYC | Other | — | 06020 | |
| 5 Mar 2026, 06:11 | Joint Company Secretary Appointment | Company Administration | — | 12007 | |
| 4 Mar 2026, 20:29 | Completion of Retail Entitlement Offer | Capital Raising | MS | 06008 | |
| 27 Feb 2026, 19:04 | PKD Clinical Trial - Approval to Escalate Dosing | Company Update | MS | 11001 | |
| 25 Feb 2026, 20:35 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 24 Feb 2026, 20:18 | 2026 Q1 Investor Update | Presentations | — | 03026 | |
| 24 Feb 2026, 05:47 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 18 Feb 2026, 20:47 | Application for quotation of securities - PYC | Other | — | 06020 | |
| 13 Feb 2026, 23:29 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 12 Feb 2026, 22:39 | Cleansing Notice under Section 708A(5)(e) | Securities Administration | — | 06018 | |
| 11 Feb 2026, 22:45 | Application for quotation of securities - PYC | Other | — | 06020 | |
| 10 Feb 2026, 00:32 | Despatch of Retail Offer Booklet | Capital Raising | — | 06008 | |
| 9 Feb 2026, 20:23 | Notification to Ineligible Retail Shareholders | Capital Raising | — | 06008, 16002 | |
| 9 Feb 2026, 20:21 | Retail Offer Booklet | Capital Raising | MS | 03026, 06008, 06010 | |
| 5 Feb 2026, 23:09 | Investor Webinar | Presentations | — | 14014 | |
| 4 Feb 2026, 20:39 | Completion of Placement and Institutional Entitlement Offer | Capital Raising | MS | 06003, 06008, 09014 |
1–50 of 95
1 / 2